Results 231 to 240 of about 1,343,805 (370)

Chronic metabolic acidosis enhances NHE-3 protein abundance and transport activity in the rat thick ascending limb by increasing NHE-3 mRNA. [PDF]

, 1997
Kamel Laghmani, Pascale Borensztein, Patrice M. Ambühl, Marc Froissart, Maurice Bichara, Orson W. Moe, Robert J. Alpern, M. Paillard   +7 more
openalex   +1 more source

N‐lactoyl amino acids are potential biomarkers for insulin resistance and diabetic complications

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims N‐lactoyl amino acids (Lac‐AA) are emerging as crucial players in metabolic research, with potential implications for disease mechanisms and therapeutic interventions. This study exploress the role of Lac‐AA in insulin resistance, type 2 diabetes (T2D), and its complications.
Khaled Naja, Asma A. Elashi, Najeha Anwardeen, Aleem Razzaq, Laila Hedaya, Shamma Almuraikhy, Ilhame Diboun, Karsten Suhre, Omar AlBagha, Mohamed A. Elrayess   +9 more
wiley   +1 more source

Carbonic anhydrase IX promotes acute lung injury and mortality in females during metabolic acidosis and pneumonia. [PDF]

Am J Physiol Lung Cell Mol Physiol
Stevens RP, Holston J, Maatouk K, Zhou C, Stone M, Pastukh VV, Francis CM, Kumar S, Gwin MS, Sayner SL, Stevens T, Lee JY.   +11 more
europepmc   +1 more source

The effects of metabolic acidosis on renal function of fetal sheep.

, 1988
Greg Kesby, Eugenie R. Lumbers
openalex   +2 more sources

Evidence for an independent role of metabolic acidosis on nutritional status in haemodialysis patients [PDF]

, 1998
Ezio Movilli, Nicola Bossini, Battista Fabio Viola, Corrado Camerini, Giovanni Cancarini, P. Feller, A. Strada, R Maiorca   +7 more
openalex   +1 more source

Clinical features and outcomes of diabetic ketoacidosis in patients using SGLT2 inhibitors: A systematic review and meta‐analysis

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Sodium‐glucose cotransporter‐2 inhibitors (SGLT2i) are effective antihyperglycaemic agents; however, they also increase the risk of diabetic ketoacidosis (DKA). As the clinical evidence comparing DKA features between SGLT2i users and non‐users remains limited due to the low incidence of DKA, this study aimed to compare the clinical ...
Dahyeon Lee, Gayeong Seo, Yunha Kim, Jea Young Min, Jeong Yee   +4 more
wiley   +1 more source

Severe Anion Gap Metabolic Acidosis From Isopropyl Alcohol and Alcoholic Ketoacidosis: A Diagnostic Challenge. [PDF]

Cureus
Cafuli A, Thorpe D, Johnson D, Bhola K, Jain D.   +4 more
europepmc   +1 more source

Effect of Metabolic Acidosis on the Potassium Content of Bone [PDF]

, 1997
David A. Bushinsky, Konstantin L. Gavrilov, Jan M. Chabala, J.D.B. Featherstone, R. Levi‐Setti   +4 more
openalex   +1 more source

Ketosis and ketoacidosis in hospitalized patients receiving SGLT2 inhibitor therapy

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims The use and safety of sodium‐glucose co‐transporter 2 inhibitors (SGLT2i) in hospital are controversial due to the risk of ketoacidosis. We aimed to describe rates of ketosis, ketoacidosis, and acidosis in patients with type 2 diabetes treated with in‐hospital SGLT2i use.
Frank M. Gao, Kartik Kishore, Dinesh Pandey, Hossein Jahanabadi, Meg Stevens, Ashani Lecamwasam, Rinaldo Bellomo, Leonid Churilov, Elif I. Ekinci   +8 more
wiley   +1 more source

Unmasking Distal Renal Tubular Acidosis in a Young Female: A Case of Metabolic Acidosis With Hypokalemic Paraparesis. [PDF]

Cureus
Uzzaman GR, Isar MM, Nahar SJ, Rana N, Moonmoon T.   +4 more
europepmc   +1 more source